The NextGen Oncology Group concerns itself with the further development of precision oncology treatment. Since tumors are as individual as a fingerprint, cancer treatment can only be successful it takes this individuality into account. Using highly innovative procedures, we determine a patient’s molecular fingerprint. Pan-genomic gene activity analysis, next-generation mutation analysis, and many other procedures are the technologies necessary to personalize treatment.
The standard cytotoxic chemotherapy has long since been overtaken by the intelligent, personalized targeted therapies that are now at the heart of scientific inquiry.
Modern, molecular-genetic technologies are the basis that allows identifying individual treatment targets. The recent development in cancer vaccines has also raised high expectations and hopes. By analyzing the entire human genome, a tumor’s individual mutations can be determined. This then allows creating absolutely personal vaccinations which are as individual as a fingerprint. These new therapeutic options will significantly change the treatment of tumor diseases in the years to come.